GT Biopharma (GTBP) had the highest return in August 2017 by a US stock in the Nasdaq Composite (IXIC), returning 55,257.1%.
| ASSET | MONTH | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | August 2017 | 55,257.14% |
Flux Power (FLUX) | August 2017 | 1,114.63% |
BTCS (BTCS) | August 2017 | 124.68% |
FingerMotion (FNGR) | August 2017 | 124.55% |
CareDx (CDNA) | August 2017 | 111.85% |
Nextplat (NXPL) | August 2017 | 100% |
Golden Matrix (GMGI) | August 2017 | 100% |
Zynex (ZYXI) | August 2017 | 94.25% |
Nutex Health (NUTX) | August 2017 | 91.01% |
Usio (USIO) | August 2017 | 81.54% |
Loop Industries (LOOP) | August 2017 | 74.1% |
GlucoTrack (GCTK) | August 2017 | 71.43% |
Heritage Global (HGBL) | August 2017 | 71.43% |
Freedom (FRHC) | August 2017 | 69% |
Avalon GloboCare (ALBT) | August 2017 | 68.69% |
Netcapital (NCPL) | August 2017 | 66.67% |
Tandem Diabetes Care (TNDM) | August 2017 | 64.71% |
Veritone (VERI) | August 2017 | 63.96% |
Arrowhead Pharmaceuticals (ARWR) | August 2017 | 60% |
Westport Fuel Systems (WPRT) | August 2017 | 57.65% |
Abeona Therapeutics (ABEO) | August 2017 | 56.55% |
MannKind (MNKD) | August 2017 | 55.64% |
Sangamo Therapeutics (SGMO) | August 2017 | 55.23% |
Calumet Specialty Products Partners (CLMT) | August 2017 | 53.85% |
XOMA (XOMA) | August 2017 | 53.81% |
